Ratings Sharda Cropchem Limited Bombay S.E.

Equities

SHARDACROP

INE221J01015

Market Closed - Bombay S.E. Other stock markets 06:00:53 2024-07-09 am EDT			5-day change	1st Jan Change
524.8 ^INR	+2.25%		+6.89%	+15.82%

May. 14	Sharda Cropchem Limited Provides Earnings Guidance for the Fiscal Year 2025	CI
May. 14	Transcript : Sharda Cropchem Limited, Q4 2024 Earnings Call, May 14, 2024

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
According to Refinitiv, the company's ESG score for its industry is poor.

Strengths

Analysts covering this company mostly recommend stock overweighting or purchase.
Over the past four months, analysts' average price target has been revised upwards significantly.
Analyst opinion has improved significantly over the past four months.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 239.14 times its estimated earnings per share for the ongoing year.
The company is highly valued given the cash flows generated by its activity.
The company is not the most generous with respect to shareholders' compensation.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
Over the past twelve months, analysts' consensus has been significantly revised downwards.
The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Agricultural Chemicals

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
SHARDA CROPCHEM LIMITED	+15.82%	556M		D+
CORTEVA, INC.	+7.93%	36.05B		C
PHOSAGRO	-.--%	11.72B	-	B+
THE FERTILISERS AND CHEMICALS TRAVANCORE LIMITED	+37.17%	8.61B	-	C-
PI INDUSTRIES LIMITED	+9.97%	6.83B		B-
FMC CORPORATION	-10.82%	7.02B		A
ICL GROUP LTD	-12.27%	5.63B		B+
OCI N.V.	-12.00%	5.29B		B
UPL LIMITED	-4.03%	5.11B		C+
YUNNAN YUNTIANHUA CO., LTD.	+23.59%	4.87B		B-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes